(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(2.16%) $83.11
(1.98%) $1.752
(1.90%) $2 254.80
(1.41%) $25.10
(1.45%) $922.85
(0.37%) $0.927
(0.69%) $10.84
(0.11%) $0.792
(0.14%) $92.57
Quarter results tomorrow
(bmo 2024-03-29)
Expected move: +/- 14.07%
Live Chart Being Loaded With Signals
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs...
Stats | |
---|---|
Today's Volume | 124 441 |
Average Volume | 142 672 |
Market Cap | 59.25M |
EPS | $-0.0800 ( 2023-11-14 ) |
Next earnings date | ( $-0.0800 ) 2024-03-29 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.39 |
ATR14 | $0.0230 (1.40%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-12 | Taitel Haya | Buy | 9 500 | Ordinary Shares, par value NIS 0.0000769 per share |
2024-01-10 | Taitel Haya | Buy | 7 615 | Ordinary Shares, par value NIS 0.0000769 per share |
2024-01-01 | Taitel Haya | Buy | 108 333 | Stock Option (right to buy) |
2024-01-01 | Garceau Roger | Buy | 108 333 | Stock Option (right to buy) |
2024-01-01 | Malca Yonatan | Buy | 108 333 | Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 89 transactions |
Buy: 4 333 534 | Sell: 4 161 674 |
Volume Correlation
Entera Bio Ltd Correlation
10 Most Positive Correlations | |
---|---|
TITN | 0.854 |
TBLA | 0.849 |
OPNT | 0.84 |
OFIX | 0.838 |
NAVI | 0.835 |
LCAA | 0.834 |
ATEC | 0.831 |
ALSA | 0.828 |
WDAY | 0.827 |
GLLI | 0.825 |
10 Most Negative Correlations | |
---|---|
AVO | -0.847 |
BLIN | -0.845 |
GETVV | -0.84 |
GLUE | -0.839 |
SIDU | -0.837 |
ATAI | -0.824 |
BIMI | -0.819 |
CEG | -0.816 |
DRUG | -0.814 |
GPOR | -0.813 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Entera Bio Ltd Correlation - Currency/Commodity
Entera Bio Ltd Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-56 000.00 (0.00 %) |
EPS: | $-0.310 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $-13 000.00 (0.00 %) |
EPS: | $-0.0672 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-14 000.00 (0.00 %) |
EPS: | $-0.0826 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-15 000.00 (0.00 %) |
EPS: | $-0.0807 |
Financial Reports:
No articles found.
Entera Bio Ltd
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators